Cargando…
1355. Efficacy and Tolerability of Linezolid Adjunctive Treatment for Nontuberculous Mycobacterial Infection in Patients with Acquired Anti-Interferon-Gamma Autoantibody
BACKGROUND: Despite a long duration of combined oral antimycobacterial drugs, relapse/ reinfection of nontuberculous mycobacteria (NTM) is common among patients with anti-interferon gamma autoantibodies (anti-IFN-γ auto-Abs). METHODS: We reported here, an interim analysis of the prospective study of...
Autores principales: | Chavapradit, Natthakit, Suputtamongkol, Yupin, Angkasekwinai, Nasikarn, Phoompoung, Pakpoom, Chirapapisan, Niphon, Foongladda, Suporn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809374/ http://dx.doi.org/10.1093/ofid/ofz360.1219 |
Ejemplares similares
-
Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
por: Phoompoung, Pakpoom, et al.
Publicado: (2017) -
Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies
por: Angkasekwinai, Nasikarn, et al.
Publicado: (2019) -
Clinical Characteristics and Treatment Outcomes for Patients Infected with Mycobacterium haemophilum
por: Nookeu, Pornboonya, et al.
Publicado: (2019) -
Disseminated cryptococcosis in Crohn’s disease: a case report
por: Chavapradit, Natthakit, et al.
Publicado: (2018) -
HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies
por: Pithukpakorn, Manop, et al.
Publicado: (2015)